CancerLinQ, a ConcertAI initiative, is a health technology company focused on improving quality of care, advancing biomedical research, and improving health outcomes for all patients with cancer.
CancerLinQ’s products and services reflect a deep understanding of the needs of oncologists, cancer centers, and researchers. We are bilingual by design: fluent in both the language of oncology and technology. As a trusted partner to over 100 cancer centers and community oncology practices, CancerLinQ is uniquely positioned to advance cancer care and research.
Learn more at www.cancerlinq.org.